This spring, Fordham will offer a new master’s degree in biotechnology.
Designed for working professionals, the 30-credit degree will give students the scientific knowledge and technical skills needed to succeed in a growing field where groundbreaking developments such as gene editing and personalized medicine are advancing at a rapid pace.
The degree can be completed in one year and offers three tracks: The first, Business and Law/Regulatory, will start in January. Two others, Biochemical/Biomolecular Technologies, and Data Analytics/Informatics, will be open for enrollment in September 2025. A fourth, generalized track that allows students to personalize their interests will also be open in September.
Biotechnology Is a Growing Field
Falguni Sen, Ph.D., head of Fordham’s Global Healthcare Innovation Management Center, said
hiring in the field of biotechnology is expected to increase.
“We see the potential for major growth taking place broadly in the life sciences areas, which includes biotechnology,” said Sen, who oversees the program.
Statistics paint an encouraging picture of the field. According to IBIS World Industry Reports, the market size of the U.S. biotechnology industry grew 7.7% per year on average between 2018 and 2023.
The industry, which combines engineering and natural sciences to create commercially viable therapeutics, is also important to New York City’s economy. In December, Mayor Eric Adams signed legislation offering tax incentives for growing biotech companies to create jobs in the city. According to the city’s Economic Development Corporation, an estimated 16,000 new jobs are expected to be created in the field by 2026.
What Can You Do with a Biotechnology Degree?
Sen said the specialization tracks were specifically tailored to the areas of the field where there are opportunities. A student who recently graduated with a bachelor’s degree in biology and aspires to be a scientist or scientist’s assistant would benefit from the Biochemical/Biomolecular Technologies concentration. Someone who is already working in the industry and wants to include a focus on AI, on the other hand, might be drawn to the Data Analytics/Informatics specialization.
“The informatics track allows you to become a specialist in the analytics side, but you’re not just a run-of-the-mill analytics person. You’ll be an analytics person who knows the biotech industry. That gives you a leg up,” said Sen.
Sen noted that because biotechnology is a fertile area for startup businesses, the Business and Law/Regulatory track was designed for anyone who is working in the industry and wants to strike off on their own.
“They might have a Ph.D. already, but they have an idea and really want to be an entrepreneur. They need to know what the regulatory system is, how to get venture money, how to do all of that,” he said.
Other fields graduates will be equipped for include finance, government, compliance, and biopharma.
Practical Biotech Degree Offers Flexibility and Hybrid Learning
Classes are a hybrid of in-person instruction and online learning, with flexible schedules designed for working professionals.
Several new courses, such as AI in Biotech, Marketing in Biotech, and Strategic Entrepreneurship and Business Development, have been created specifically for the degree.
“What’s wonderful about this degree is that there is a core of five courses that really give you a sense of how this industry is structured, how it makes money, what its peculiarities are, and all the possibilities that are out there,” said Sen.
“You can take all of this knowledge and harness it for whatever direction you want to take.”
The program is being offered through the Graduate School of Arts and Sciences (GSAS) and leverages the expertise of faculty from the GSAS, the Gabelli School of Business, and Fordham Law.
